当前位置:SCI论文发表网>SCI期刊>ACS Infectious Diseases

ACS Infectious Diseases

SCI之家头像
创始人 研老师

期刊基本信息

期刊名称:ACS Infectious Diseases

出版国家或地区:UNITED STATES

是否OA:No

期刊ISSN:2373-8227

期刊官方网站:http://pubs.acs.org/journal/aidcbc

期刊投稿网址:https://acs.manuscriptcentral.com/acs

涉及的研究方向:CHEMISTRY, MEDICINALINFECTIOUS DISEASES&nb-INFECTI

期刊数据表:

最新中科院JCR分区
大类(学科)
小类(学科)
JCR学科排名
医学
CHEMISTRY, MEDICINAL(化学,医药) 2区 INFECTIOUS DISEASES(传染病) 2区
6/59 17/88
最新的影响因子
4.614
最新公布的期刊年发文量
年度总发文量 年度论文发表量 年度综述发表量
88 86 2
总被引频次 1459
特征因子 0.005500

ACS Infectious Diseases英文简介:

About the JournalACS Infectious Diseases is the first journal to highlight chemistry and its role in the multidisciplinary and collaborative field of infectious disease research. The scope of the journal encompasses all aspects of chemistry relating to infectious diseases research including research on pathogens, host-pathogen interactions, therapeutics, diagnostics, vaccines, drug-delivery systems, and other biomedical technology development pertaining to infectious diseases.With editors well-versed in both chemistry and the biology of infectious diseases, the journal aims to bridge the gap between these two disciplines. ACS Infectious Diseases welcomes submission of articles with a balance of chemistry and biology, and encourages discussions centered on specific pathogen- and disease-related issues.Journal ScopeTopics covered by the journal include but are not limited to the following:Pathogens and Host-Pathogen InteractionsUse of structural biology, chemical biology, glycobiology, physical chemistry, nucleic acid chemistry, and biochemistry to elucidate molecular mechanisms of pathogenesisDevelopment of tools to dissect mechanisms of pathogenesisTherapeuticsUse of target-, phenotypic-, or computational-based approaches for discovery and development of new agents to treat infectious diseases, with an emphasis on establishing mechanism of action, understanding binding mode and inhibitory mechanism, and/or discussing pathogen-specific challenges to drug developmentDevelopment of new technologies to facilitate characterization, validation, and prioritization of potential drug targets or to assess the physicochemical bases for cellular penetration of anti-infectivesMechanistic investigations of antimicrobial resistanceVaccinesDiscovery and development of synthetic vaccines and small molecule vaccine adjuvantsStructural, physical, or computational investigations of epitope bindingDiagnosticsDevelopment of novel and improved diagnostics using physical, surface, analytical, and nano chemistry techniquesUse of structural biology, molecular biology, and chemical biology to investigate diagnostics targetsDrug Delivery SystemsUse of novel materials and technologies, such as nanotechnologies, for delivery of antimicrobial agents

ACS Infectious Diseases中文简介:

关于杂志ACS传染病是第一本强调化学及其在传染病研究的多学科和协作领域中的作用的杂志。该杂志的范围包括与传染病研究有关的化学的所有方面,包括对病原体的研究、宿主与病原体的相互作用、治疗学、诊断学、疫苗、药物输送系统以及与传染病有关的其他生物医学技术的发展。编辑们精通传染病的化学和生物学,该杂志旨在弥合这两门学科之间的鸿沟。ACS传染病欢迎提交化学和生物学平衡的文章,并鼓励围绕特定病原体和疾病相关问题进行讨论。期刊范围该期刊涵盖的主题包括但不限于以下内容:病原体与宿主-病原体相互作用运用结构生物学、化学生物学、糖生物学、物理化学、核酸化学、生物化学等,阐明发病的分子机制发展工具解剖发病机制治疗利用目标、表型或基于计算的方法发现和开发治疗传染病的新制剂,重点是建立作用机制、理解结合模式和抑制机制,以及/或讨论药物开发面临的病原体特异性挑战开发新技术,以促进对潜在药物靶点的鉴定、验证和优先排序,或评估抗感染药物的细胞渗透的物理化学基础抗菌素耐药性的机制研究疫苗合成疫苗和小分子疫苗佐剂的发现和开发表位结合的结构、物理或计算研究诊断利用物理、表面、分析和纳米化学技术开发新的和改进的诊断方法利用结构生物学、分子生物学和化学生物学研究诊断目标药物输送系统利用新材料和新技术,如纳米技术,来运送抗菌药物

CiteScore历年趋势图

ACS Infectious Diseases在线问答:

© http://www.scizj.com/sci/13885.html
SCI之家介绍

SCI之家专业从事SCI期刊、SSCI期刊、EI源刊、SCOPUS期刊、论文咨询服务。SCI之家有来自美国、新加坡、马来西亚的专业英文母语化编审指导团队为您提供专业的英文论文母语润色服务。专注国际学术咨询服务,我们是认真的!

投稿咨询

SCOPUS知识>
关注:601+
2024-10-28 16:10:34
关注:723+
2024-04-22 17:04:35
关注:706+
2024-02-19 17:02:15
关注:652+
2024-01-15 17:01:08
关注:364+
2024-01-12 17:01:11
关注:402+
2023-12-28 17:12:03
最新SCI问答 >
关注:687+
2024-11-20 18:11:41
关注:546+
2024-11-18 18:11:35
关注:505+
2024-11-16 15:11:53
热门SCI问答 >
关注:927+
2024-11-18 18:11:32
关注:869+
2024-11-19 18:11:11
关注:762+
2024-11-14 18:11:36
EI期刊百问 >
关注:636+
2024-10-19 16:10:37
关注:475+
2024-09-14 11:09:45
关注:749+
2024-09-10 15:09:57
关注:374+
2024-07-23 15:07:04
关注:552+
2024-07-19 16:07:20
关注:490+
2024-07-17 11:07:46